Robuta

Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.

This page provides downloadable Takeda Pharmaceuticals charters and reports including our articles of incorporation.

Learn about Takeda's corporate responsibility initiatives to help prevent maternal deaths in developing countries.

Learn how our programs are broadening patient access to innovative medicines and vaccines.

Global demand for plasma-derived therapies, particularly immunoglobulins, has increased dramatically over the last 15 years and continues to grow. Takeda is...

The Takeda leadership team is committed to developing strategy and executing it in a way that puts the patient at the center of everything we do.

Novartis has entered an agreement to acquire Endocyte for approximately $2.1bn.

Kimberly A. Reed is an External Director at Takeda Pharmaceuticals Ltd.

Takeda's Neuroscience Digital Health & Corporate Partnership Program seeks innovative digital health solutions to enhance the quality of life for patients with...

The ISPE Women in Pharma Workshop sponsored by Takeda will be a 2-day event in Vienna, Austria in September 2024 aimed for middle to senior management, experts...

Michel Orsinger is an External Director at Takeda Pharmaceutical Company Ltd.

Access Takeda's directory of downloadable reports on sustainability, corporate overview, and annual reports.

Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.

At the Shonan Health Innovation Park, Takeda has launched a new site to enhance scientific innovation. With experts from the industry, including venture...

Takeda's Global CSR Program supports activities in developing countries that prevent disease and improve access to quality diagnosis and treatment.